The internet has become obsessed with “microdosing” GLP-1 drugs for longevity — but scientists say there’s no evidence to suggest it works.
GLP-1s like Ozempic and Mounjaro were initially designed and approved to treat type 2 diabetes, but in recent years, millions of Americans have turned to them for weight loss management. Now, The Washington Post reports that a GLP-1 “microdosing” trend is sweeping the internet, and more than a dozen telehealth companies and medical practices have promoted taking small doses of the drugs for longevity.
